Nephrotic-range proteinuria on interferon-β treatment: immune-induced glomerulonephritis or other pathway?
- Published in:
- Clinical Kidney Journal, 2014, v. 7, n. 2, p. 190, doi. 10.1093/ckj/sfu016
- By:
- Publication type:
- Article
Works matching DE "BETA interferon"
Results: 22
1
2
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086663
- By:
- Publication type:
- Article
3
Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 19, p. 4892, doi. 10.1002/cncr.27395
- By:
- Publication type:
- Article
4
influenza a Virus Pa antagonizes interferon-β by interacting with interferon regulatory Factor 3.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01051
- By:
- Publication type:
- Article
5
Commentary on "Localized pigmentation disorder after subcutaneous pegylated interferon beta 1a injection" by Coghe et al.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 2, p. 233, doi. 10.1177/1352458517719153
- By:
- Publication type:
- Article
6
Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 4, p. 588, doi. 10.1177/1352458516657440
- By:
- Publication type:
- Article
7
Interferon beta-1a long-term therapy related to pulmonary arterial hypertension in multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 11, p. 1495, doi. 10.1177/1352458515618020
- By:
- Publication type:
- Article
8
The best clinical paper on multiple sclerosis in 2012: Commentary.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
9
Intramuscular interferon beta-1a is effective in Japanese patients with relapsing–remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 12, p. 1782, doi. 10.1177/1352458512442261
- By:
- Publication type:
- Article
10
Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins.
- Published in:
- Virology Journal, 2016, v. 13, n. 1, p. 1, doi. 10.1186/s12985-016-0573-8
- By:
- Publication type:
- Article
11
Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferon.
- Published in:
- ClinicoEconomics & Outcomes Research, 2018, v. 10, p. 723, doi. 10.2147/CEOR.S163907
- By:
- Publication type:
- Article
12
Investigating the effects eight weeks of non-continuous aerobic exercise on the levels of angiopoietin2-like protein and interferon beta in rats suffering from coronary artery disease.
- Published in:
- National Journal of Physiology, Pharmacy & Pharmacology, 2018, v. 8, n. 4, p. 563, doi. 10.5455/njppp.2018.8.1143710122017
- By:
- Publication type:
- Article
13
Beta-interferon exposure and onset of secondary progressive multiple sclerosis.
- Published in:
- European Journal of Neurology, 2015, v. 22, n. 6, p. 990, doi. 10.1111/ene.12698
- By:
- Publication type:
- Article
14
MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up.
- Published in:
- BMC Neurology, 2012, v. 12, n. 1, p. 1, doi. 10.1186/1471-2377-12-107
- By:
- Publication type:
- Article
15
Overexpression of Recombinant Human Beta Interferon (rhINF-β) in Periplasmic Space of Escherichia coli.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2014, v. 13, p. 151
- By:
- Publication type:
- Article
16
Immunization of Knock-Out α/β Interferon Receptor Mice against High Lethal Dose of Crimean-Congo Hemorrhagic Fever Virus with a Cell Culture Based Vaccine.
- Published in:
- PLoS Neglected Tropical Diseases, 2015, v. 9, n. 3, p. 1, doi. 10.1371/journal.pntd.0003579
- By:
- Publication type:
- Article
17
Short- and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome: a systematic review of randomised controlled trials and network meta-analysis.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 5, p. 999, doi. 10.1007/s00415-018-8752-8
- By:
- Publication type:
- Article
18
Alemtuzumab for multiple sclerosis: a new age of immunotherapy.
- Published in:
- Journal of Neurology, 2013, v. 260, n. 1, p. 343, doi. 10.1007/s00415-012-6786-x
- By:
- Publication type:
- Article
19
Phospholipase D1 expression analysis in relapsing-remitting multiple sclerosis patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
20
Beta-interferon therapy in relapsing and remitting multiple sclerosis - challenges in an emerging country.
- Published in:
- International Journal of Nutrition, Pharmacology, Neurological Diseases, 2014, v. 4, p. S34, doi. 10.4103/2231-0738.147464
- By:
- Publication type:
- Article
21
Interferon-beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription.
- Published in:
- Acta Medica Iranica, 2012, v. 50, n. 2, p. 97
- By:
- Publication type:
- Article
22
The bioactivity and fractionation of peptide hydrolysates in cultures of CHO cells.
- Published in:
- Biotechnology Progress, 2014, v. 30, n. 3, p. 584, doi. 10.1002/btpr.1930
- By:
- Publication type:
- Article